The voice of medical imaging and clinical oncology

endometriosis

Novel PETMR approach improves detection of endometriosis in difficult-to-assess areas

A new PETMR technique that targets fibroblast activation protein (FAP) overexpressed in endometriosis is more effective at identifying lesions than conventional imaging. According to new research published in the August issue of The Journal of Nuclear Medicine, this approach was particularly effective in regions of the pelvis and abdomen that are typically difficult to image. By […]

Read More

Imaging study indicates 99mTc-maraciclatide is a promising diagnostic and monitoring tool for endometriosis

Serac Healthcare, a clinical radiopharmaceutical company developing the molecular imaging agent 99mTc-maraciclatide, and the Nuffield Department of Women’s and Reproductive Health at the University of Oxford have had phase 2 data published from the DETECT (Detecting endometriosis expressed integrins using technetium-99m) imaging study. Published online in The Lancet Obstetrics, Gynaecology & Women’s Health, the study […]

Read More